Konstantin K. Osadchiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Konstantin K. Osadchiy has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Array E. Bragina
Sechenov First Moscow State Medical University (Sechenov University)
14 shared publications - Valerii I. Podzolkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
13 shared publications - Yulia N. Rodionova
Sechenov First Moscow State Medical University (Sechenov University)
9 shared publications - Array I. Tarzimanova
Sechenov First Moscow State Medical University (Sechenov University)
5 shared publications - Maria K. Vasilchenko
Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Darya A. Bayutina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications
Latest Publications
- Open Access
- 20 October 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (9) , 773-780
Phenotypic clusters of obesity: gender, clinical, laboratory and genetic characteristics
Aim. To identify phenotypic clusters of patients with various types of obesity and to study their gender, clinical, laboratory and genetic characteristics. Materials and methods. 100 patients (47 men and 53 women, median age 58.5 [50; 69] years) were included in the cross-sectional study. All patients underwent chest and retroperitoneal space computed tomography with the calculation of pericardial, perivascular adipose tissue volumes and the thickness of perirenal fat. Alleles and genotypes of the peroxisome proliferator activated receptor gamma (PPARG) rs1801282 polymorphism, angiotensin II receptor type 1 (AGTR1) rs5186 polymorphism, and vascular endothelial growth factor A (VEGF-A) rs699947 polymorphism were identified in all patients. Cluster analysis was performed with python version 3.11. using the k-means algorithm. Silhouette value 0.2. Results. Cluster 1 (n=36) consisted of middle-aged patients (men – 38.9%) with hypertension (HTN) – 100%, combined obesity [general obesity (GO) – 61%, abdominal obesity (AO) – 100%, ectopic obesity – 80.5%] and dyslipidaemia (77.8%). Cluster 2 included 14 patients: elderly (77.8%) men (71.4%) with HTN (100%), combined obesity (GO – 92.8%, AO – 85.7%, ectopic obesity – 100%), high incidence of dyslipidaemia (92.8%) and target organ damage. Cluster 3 consisted of 21 patients, mostly elderly (87.5%) women (76.2%) with HTN (90.1%), AO (80.9%), without GO (0%) and perirenal obesity (0%). Cluster 4 consisted of 29 patients, mostly young men without HTN (0%) with isolated AO (72.4%). The highest prevalence of risky alleles of the studied polymorphisms was found in cluster 2 (25, 32.1, 64.3%). The frequency of risky alleles was low 10.3, 20.7 and 43.1% in the most metabolically favourable cluster 4 compared to cluster 2. Conclusion. We identified 4 clusters of obese patients in our study. Among them, the most unfavorable from a metabolic and genetic point of view was cluster 2, and the most favourable was cluster 4.
- 20 October 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (9) , 773-780
Open AccessPhenotypic clusters of obesity: gender, clinical, laboratory and genetic characteristics
Aim. To identify phenotypic clusters of patients with various types of obesity and to study their gender, clinical, laboratory and genetic characteristics. Materials and methods. 100 patients (47 men and 53 women, median age 58.5 [50; 69] years) were included in the cross-sectional study. All patients underwent chest and retroperitoneal space computed tomography with the calculation of pericardial, perivascular adipose tissue volumes and the thickness of perirenal fat. Alleles and genotypes of the peroxisome proliferator activated receptor gamma (PPARG) rs1801282 polymorphism, angiotensin II receptor type 1 (AGTR1) rs5186 polymorphism, and vascular endothelial growth factor A (VEGF-A) rs699947 polymorphism were identified in all patients. Cluster analysis was performed with python version 3.11. using the k-means algorithm. Silhouette value 0.2. Results. Cluster 1 (n=36) consisted of middle-aged patients (men – 38.9%) with hypertension (HTN) – 100%, combined obesity [general obesity (GO) – 61%, abdominal obesity (AO) – 100%, ectopic obesity – 80.5%] and dyslipidaemia (77.8%). Cluster 2 included 14 patients: elderly (77.8%) men (71.4%) with HTN (100%), combined obesity (GO – 92.8%, AO – 85.7%, ectopic obesity – 100%), high incidence of dyslipidaemia (92.8%) and target organ damage. Cluster 3 consisted of 21 patients, mostly elderly (87.5%) women (76.2%) with HTN (90.1%), AO (80.9%), without GO (0%) and perirenal obesity (0%). Cluster 4 consisted of 29 patients, mostly young men without HTN (0%) with isolated AO (72.4%). The highest prevalence of risky alleles of the studied polymorphisms was found in cluster 2 (25, 32.1, 64.3%). The frequency of risky alleles was low 10.3, 20.7 and 43.1% in the most metabolically favourable cluster 4 compared to cluster 2. Conclusion. We identified 4 clusters of obese patients in our study. Among them, the most unfavorable from a metabolic and genetic point of view was cluster 2, and the most favourable was cluster 4.
- Open Access
- 1 October 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (10) , 574-581
Pericardial Fat Tissue as a Predictor of the Severity of Acute Coronavirus Infection COVID-19
Background: Coronavirus disease 2019 (COVID-19) and obesity remain pressing global health concerns. Identifying predictors of severe disease is of particular importance. Pericardial fat tissue (PFT) is a known source of metainflammation due to its secretion of adipocytokines and inflammatory mediators. Moreover, cytokine storm plays a major role in COVID-19-related mortality. This study aimed to investigate the association between preexisting PFT volume and inflammatory markers in patients with COVID-19. Methods: The study included 290 hospitalized patients with confirmed COVID-19 infection. Based on PFT volume (above or below 3.45 cm3), patients were divided into two groups: with and without pericardial obesity (PO), consisting of 132 and 158 individuals, respectively. Clinical, laboratory, and imaging data were analyzed. Statistical analysis was performed in Statistica 12.0. Results: Significant intergroup differences were observed in the PO group for the following variables: male sex (P < 0.001), body mass index (BMI) (P < 0.001), obesity (P < 0.001), and history of diabetes mellitus (P = 0.003). No significant differences were found in lung computed tomography (CT) severity scores. However, patients with PO showed significantly lower oxygen saturation (SpO2) levels (P = 0.014) and a higher frequency of SpO2 ≤ 93% (P = 0.012). Ferritin levels were significantly higher in the PO group (median 440 (274.00 - 552.70) vs. 292.55 (156.00 - 521.50), P = 0.010). Linear correlation analysis revealed a positive association between PFT volume and age, BMI, glucose, ferritin, C-reactive protein, and D-dimer levels, and a negative correlation with oxygen saturation. Multivariate logistic regression confirmed an independent association between PFT volume and SpO2 ≤ 93%. Receiver operating characteristic (ROC) analysis identified a threshold PFT volume of 3.45 cm3 for predicting increased risk of severe COVID-19 (SpO2 ≤ 93%), with sensitivity of 66.7%, specificity of 65.0%, and area under the curve (AUC) of 0.710 (95% confidence interval (CI): 0.551 - 0.868, P < 0.001). Conclusions: Our data suggest that a PFT volume greater than 3.45 cm3 is a potential predictor of severe COVID-19.
- 1 October 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (10) , 574-581
Open AccessPericardial Fat Tissue as a Predictor of the Severity of Acute Coronavirus Infection COVID-19
Background: Coronavirus disease 2019 (COVID-19) and obesity remain pressing global health concerns. Identifying predictors of severe disease is of particular importance. Pericardial fat tissue (PFT) is a known source of metainflammation due to its secretion of adipocytokines and inflammatory mediators. Moreover, cytokine storm plays a major role in COVID-19-related mortality. This study aimed to investigate the association between preexisting PFT volume and inflammatory markers in patients with COVID-19. Methods: The study included 290 hospitalized patients with confirmed COVID-19 infection. Based on PFT volume (above or below 3.45 cm3), patients were divided into two groups: with and without pericardial obesity (PO), consisting of 132 and 158 individuals, respectively. Clinical, laboratory, and imaging data were analyzed. Statistical analysis was performed in Statistica 12.0. Results: Significant intergroup differences were observed in the PO group for the following variables: male sex (P < 0.001), body mass index (BMI) (P < 0.001), obesity (P < 0.001), and history of diabetes mellitus (P = 0.003). No significant differences were found in lung computed tomography (CT) severity scores. However, patients with PO showed significantly lower oxygen saturation (SpO2) levels (P = 0.014) and a higher frequency of SpO2 ≤ 93% (P = 0.012). Ferritin levels were significantly higher in the PO group (median 440 (274.00 - 552.70) vs. 292.55 (156.00 - 521.50), P = 0.010). Linear correlation analysis revealed a positive association between PFT volume and age, BMI, glucose, ferritin, C-reactive protein, and D-dimer levels, and a negative correlation with oxygen saturation. Multivariate logistic regression confirmed an independent association between PFT volume and SpO2 ≤ 93%. Receiver operating characteristic (ROC) analysis identified a threshold PFT volume of 3.45 cm3 for predicting increased risk of severe COVID-19 (SpO2 ≤ 93%), with sensitivity of 66.7%, specificity of 65.0%, and area under the curve (AUC) of 0.710 (95% confidence interval (CI): 0.551 - 0.868, P < 0.001). Conclusions: Our data suggest that a PFT volume greater than 3.45 cm3 is a potential predictor of severe COVID-19.
- Open Access
- 29 April 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (3) , 6176
Polymorphism of the PPARG, AGTR1, VEGF-A genes: frequency and association with obesity phenotypes
Aim. To assess the association of the allele and genotype frequencies of following single nucleotide polymorphisms: rs1801282 of the peroxisome proliferator-activated receptor gamma (PPARG) gene, rs5186 of the angiotensin II receptor type 1 (AGTR1) gene, rs699947 of the vascular endothelial growth factor A (VEGF-A) gene in patients with various phenotypes of abdominal (AO) and ectopic (EO) obesity.Material and methods. The cross-sectional study included 100 Caucasian patients (47 men, 53 women, median age 58,5 [50;69] years). All patients underwent chest and retroperitoneal computed tomography with calculation of the volumes of perivascular (PVAT) and pericardial (PAT) adipose tissue, and perirenal fat thickness (PFT). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT thickness ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity. Alleles and genotypes of polymorphic markers of candidate genes were identified in all patients.Results. In the distribution of genotypes of the polymorphic marker AGTR1 rs5186, statistical significance (p=0,014) was found between the group with any type of obesity and patients without obesity; the distribution of genotypes differed from the Hardy-Weinberg equilibrium (HWE) in the EO (p=0,0009) and mixed obesity (p=0,05) groups. With regard to the marker VEGF-A rs699947, a significant increase in the frequency of the mutant allele C (62,5%, 50%, 46,3%, 47,75%, respectively) was found in the EO, AO, and EO+AO groups with any type of obesity compared to the non-obese group (40%) (χ2=10,806; p=0,013). A deviation of the frequency of VEGF-A rs699947 genotypes from HWE was found in the EO group (p=0).Conclusion. Our data suggest that single nucleotide polymorphisms PPARG rs1801282, AGTR1 rs5186, VEGF-A rs699947 may be associated with fat distribution in the body and be markers of various EO and AO phenotypes. Verification of our hypothesis requires additional studies with the inclusion of larger samples and comparison groups.
- 29 April 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (3) , 6176
Open AccessPolymorphism of the PPARG, AGTR1, VEGF-A genes: frequency and association with obesity phenotypes
Aim. To assess the association of the allele and genotype frequencies of following single nucleotide polymorphisms: rs1801282 of the peroxisome proliferator-activated receptor gamma (PPARG) gene, rs5186 of the angiotensin II receptor type 1 (AGTR1) gene, rs699947 of the vascular endothelial growth factor A (VEGF-A) gene in patients with various phenotypes of abdominal (AO) and ectopic (EO) obesity.Material and methods. The cross-sectional study included 100 Caucasian patients (47 men, 53 women, median age 58,5 [50;69] years). All patients underwent chest and retroperitoneal computed tomography with calculation of the volumes of perivascular (PVAT) and pericardial (PAT) adipose tissue, and perirenal fat thickness (PFT). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT thickness ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity. Alleles and genotypes of polymorphic markers of candidate genes were identified in all patients.Results. In the distribution of genotypes of the polymorphic marker AGTR1 rs5186, statistical significance (p=0,014) was found between the group with any type of obesity and patients without obesity; the distribution of genotypes differed from the Hardy-Weinberg equilibrium (HWE) in the EO (p=0,0009) and mixed obesity (p=0,05) groups. With regard to the marker VEGF-A rs699947, a significant increase in the frequency of the mutant allele C (62,5%, 50%, 46,3%, 47,75%, respectively) was found in the EO, AO, and EO+AO groups with any type of obesity compared to the non-obese group (40%) (χ2=10,806; p=0,013). A deviation of the frequency of VEGF-A rs699947 genotypes from HWE was found in the EO group (p=0).Conclusion. Our data suggest that single nucleotide polymorphisms PPARG rs1801282, AGTR1 rs5186, VEGF-A rs699947 may be associated with fat distribution in the body and be markers of various EO and AO phenotypes. Verification of our hypothesis requires additional studies with the inclusion of larger samples and comparison groups.
- Open Access
- 19 June 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (3) , 285-293
Ectopic adipose tissue: association of obesity phenotypes with integral metabolic indices of obesity
Aim. To study the relationship and predictive value of integral metabolic indices of obesity in the identification of ectopic obesity.Material and methods. The study included 326 patients (146 men and 180 women, mean age 61±9 years). Anthropometric data, degree of obesity, body mass index (BMI), waist circumference (WC), sagittal abdominal diameter (SAD), body obesity index (BAI), visceral obesity index (VAI), lipid accumulation index (LAP), triglycerides-glucose index (TyG) was assessed. Perivascular adipose tissue (PVAT) volume, pericardial adipose tissue (PAT) volume and thickness of perirenal fat tissue (PRF) were assessed with CT.Results. Patients were divided into groups: with isolated ectopic obesity (iEO) (n=17); with isolated abdominal obesity (iAO) (n=74); with EO variants: pericardial (PCO) (n=31), perivascular (PVO) (n=22) or perirenal (PRO) (n=33) with AO; with mixed ectopic obesity and AO (mEO+AO) (n=117), and patients without obesity (n=32). Significantly higher BMI, WC, SAD, and BAI indices were found in individuals with PCO+AO, PRO+AO and mEO+AO. The highest values of LAP were found in groups: PCO+AO, PVO+AO, PRO+AO. There was a correlation between ectopic fat depots and WC (r=0,62 for PAT, r=0,55 for PVAT and r=0,39 for PRF, p=0,01) and SAD (0,429, 0,329 and 0,435, respectively, p=0,01). Correlation was established between PAT, PRF and LAP (0,425 and 0,319, respectively, p=0,01). The highest AUC values>0,8 had models of WC and SAD in identification of PCO (0,801 and 0,801, respectively) and PRO (0,826 and 0,826, respectively). For PCO, the cut-off point of WC was 100,5 cm (specificity 72,9%, sensitivity 70,2%, p=0,000), SAD — 25 cm (specificity 73%, sensitivity 70,2%, p=0,000). For PRO, the cut-off of WC was 101 cm (specificity 71,4%, sensitivity 72,7%, p=0,000), SAD — 25 cm (specificity 71,4%, sensitivity 72,7%, p=0,000).Conclusion. Еctopic fat depots are related to the risk of metabolic disorders. Potential informative value of simple and accessible integral metabolic indices was established. WC>100,5 cm, SAD>25 cm may indicate to the presence of PCO; WC>101 cm, SAD>25 cm — to the presence of PRO.
- 19 June 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (3) , 285-293
Open AccessEctopic adipose tissue: association of obesity phenotypes with integral metabolic indices of obesity
Aim. To study the relationship and predictive value of integral metabolic indices of obesity in the identification of ectopic obesity.Material and methods. The study included 326 patients (146 men and 180 women, mean age 61±9 years). Anthropometric data, degree of obesity, body mass index (BMI), waist circumference (WC), sagittal abdominal diameter (SAD), body obesity index (BAI), visceral obesity index (VAI), lipid accumulation index (LAP), triglycerides-glucose index (TyG) was assessed. Perivascular adipose tissue (PVAT) volume, pericardial adipose tissue (PAT) volume and thickness of perirenal fat tissue (PRF) were assessed with CT.Results. Patients were divided into groups: with isolated ectopic obesity (iEO) (n=17); with isolated abdominal obesity (iAO) (n=74); with EO variants: pericardial (PCO) (n=31), perivascular (PVO) (n=22) or perirenal (PRO) (n=33) with AO; with mixed ectopic obesity and AO (mEO+AO) (n=117), and patients without obesity (n=32). Significantly higher BMI, WC, SAD, and BAI indices were found in individuals with PCO+AO, PRO+AO and mEO+AO. The highest values of LAP were found in groups: PCO+AO, PVO+AO, PRO+AO. There was a correlation between ectopic fat depots and WC (r=0,62 for PAT, r=0,55 for PVAT and r=0,39 for PRF, p=0,01) and SAD (0,429, 0,329 and 0,435, respectively, p=0,01). Correlation was established between PAT, PRF and LAP (0,425 and 0,319, respectively, p=0,01). The highest AUC values>0,8 had models of WC and SAD in identification of PCO (0,801 and 0,801, respectively) and PRO (0,826 and 0,826, respectively). For PCO, the cut-off point of WC was 100,5 cm (specificity 72,9%, sensitivity 70,2%, p=0,000), SAD — 25 cm (specificity 73%, sensitivity 70,2%, p=0,000). For PRO, the cut-off of WC was 101 cm (specificity 71,4%, sensitivity 72,7%, p=0,000), SAD — 25 cm (specificity 71,4%, sensitivity 72,7%, p=0,000).Conclusion. Еctopic fat depots are related to the risk of metabolic disorders. Potential informative value of simple and accessible integral metabolic indices was established. WC>100,5 cm, SAD>25 cm may indicate to the presence of PCO; WC>101 cm, SAD>25 cm — to the presence of PRO.
- Open Access
- 26 April 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (6) , 3980
Ectopic adipose tissue: frequency and clinical characteristics of obesity phenotypes in patients
Aim. To study the frequency and clinical characteristics of ectopic obesity in patients with different body weights and hypertension (HTN).Material and methods. The study included 326 patients (145 men and 181 women, mean age 63±8 years). Patients underwent chest and retroperitoneal space computed tomography with calculation of the volumes of perivascular adipose tissue (AT) (PVAT), pericardial AT (PAT) and perirenal fat thickness (PFT) using specialized software QCT Pro Tissue Composition Module (Mindways Software, USA). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity.Results. When studying the prevalence of ectopic (EO) and abdominal (AO) obesity phenotypes, patients were divided into groups: 1) with isolated EO without AO (n=17), 2) with PCO and AO (n=31), 3) with PVO and AO (n=22), 4) with PRO and AO (n=33), 5) with mixed EO (PKO+PVO, or PKO+PRO, or PVO+PRO, or PKO+PVO+PRO) and AO, 6) with isolated AO without EO (n=74), 7) without obesity (n=32). Isolated EO was significantly more common in individuals with normal and overweight compared to patients with obesity: 8,9 and 12 vs 1,1% (p=0,001), respectively. The prevalence of the mixed EO+AO phenotype in obese patients was significantly higher than in patients with normal and overweight as follows: 41,7 vs 19,6 and 21,7% (p=0,001), respectively. In patients with HTN, PVO+AO was significantly more common compared to patients without HTN as follows: 12,8 vs 3% (p=0,001), respectively.Conclusion. The study results indicate the heterogeneity of the distribution of obesity phenotypes in people with different body mass index, which emphasizes the importance of taking into account all its variants, including EO, for timely and adequate cardiovascular risk assessment.
- 26 April 2024
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (6) , 3980
Open AccessEctopic adipose tissue: frequency and clinical characteristics of obesity phenotypes in patients
Aim. To study the frequency and clinical characteristics of ectopic obesity in patients with different body weights and hypertension (HTN).Material and methods. The study included 326 patients (145 men and 181 women, mean age 63±8 years). Patients underwent chest and retroperitoneal space computed tomography with calculation of the volumes of perivascular adipose tissue (AT) (PVAT), pericardial AT (PAT) and perirenal fat thickness (PFT) using specialized software QCT Pro Tissue Composition Module (Mindways Software, USA). PAT volume ≥3,2 cm3, PVAT volume ≥0,4 cm3, PFT ≥1,91 cm were considered criteria for pericardial (PCO), perivascular (PVO) and perirenal (PRO) obesity.Results. When studying the prevalence of ectopic (EO) and abdominal (AO) obesity phenotypes, patients were divided into groups: 1) with isolated EO without AO (n=17), 2) with PCO and AO (n=31), 3) with PVO and AO (n=22), 4) with PRO and AO (n=33), 5) with mixed EO (PKO+PVO, or PKO+PRO, or PVO+PRO, or PKO+PVO+PRO) and AO, 6) with isolated AO without EO (n=74), 7) without obesity (n=32). Isolated EO was significantly more common in individuals with normal and overweight compared to patients with obesity: 8,9 and 12 vs 1,1% (p=0,001), respectively. The prevalence of the mixed EO+AO phenotype in obese patients was significantly higher than in patients with normal and overweight as follows: 41,7 vs 19,6 and 21,7% (p=0,001), respectively. In patients with HTN, PVO+AO was significantly more common compared to patients without HTN as follows: 12,8 vs 3% (p=0,001), respectively.Conclusion. The study results indicate the heterogeneity of the distribution of obesity phenotypes in people with different body mass index, which emphasizes the importance of taking into account all its variants, including EO, for timely and adequate cardiovascular risk assessment.
- Open Access
- 2 November 2022
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 18 (5) , 516-521
Pararenalfat Tissue: Rate of Pararenal Obesity and Relation with Anthropometric Indices of Obesity
Aim. To study a rate of excessive pararenal fat tissue (PRFT) thickness and its relationship with anthropometric obesity indices.Material and methods. 372 patients (152 men and 220 women) were included in the study, the average age was 63.5±13.3 years. There were measured: height, weight, waist circumference (WC), hip circumference (HC), body mass index (BMI), WC/height ratio, sagittal abdominal diameter (SAD), body fat percentage (BFP), body surface area (BSA), body adiposity index (BAI) and visceral obesity index (VAI). All subjects underwent abdominal multispiral computed tomography. PRFT thickness was detected on a single slice at the level of the left renal vein.Results. 27% of the examined group had BMIConclusion. Excessive PRFT may be detected isolated without any external anthropometric signs of obesity, wherein it is an active component of metabolic disorders typical for obesity. The most significant indices for the detection of pararenal obesity may be WC, SAD, and BSA.
- 2 November 2022
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 18 (5) , 516-521
Open AccessPararenalfat Tissue: Rate of Pararenal Obesity and Relation with Anthropometric Indices of Obesity
Aim. To study a rate of excessive pararenal fat tissue (PRFT) thickness and its relationship with anthropometric obesity indices.Material and methods. 372 patients (152 men and 220 women) were included in the study, the average age was 63.5±13.3 years. There were measured: height, weight, waist circumference (WC), hip circumference (HC), body mass index (BMI), WC/height ratio, sagittal abdominal diameter (SAD), body fat percentage (BFP), body surface area (BSA), body adiposity index (BAI) and visceral obesity index (VAI). All subjects underwent abdominal multispiral computed tomography. PRFT thickness was detected on a single slice at the level of the left renal vein.Results. 27% of the examined group had BMIConclusion. Excessive PRFT may be detected isolated without any external anthropometric signs of obesity, wherein it is an active component of metabolic disorders typical for obesity. The most significant indices for the detection of pararenal obesity may be WC, SAD, and BSA.
- Open Access
- 24 October 2022
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 94 (9) , 1072-1077
Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics
Aim. To determine the frequency, distribution and characteristics of ectopic obesity in patients without manifested cardiovascular disease. Materials and methods. We examined 320 patients without manifested cardiovascular disease (average age 63.813.9 years), 38 of them without cardiovascular risk factors (healthy referent group). Anthropometric indicators were measured, body mass index (BMI) was calculated. Degree, type of obesity, lipid profile were evaluated. All patients underwent multi-detector chest computed tomography in spiral mode on Toshiba Aquilion Prime scanner using standardized protocol. Perivascular adipose tissue (PVAT) and pericardial adipose tissue (PAT) were detected using specialized semi-automatic software Tissue Composition Module QCTPro (Mindways Software, Inc., USA) after scanner calibration with special phantom. PAT and PVAT exceeding the 90th percentile in the healthy referent group were considered as ectopic obesity. Statistical analysis was performed using Statistica 10.0 software (StatSoft Inc., USA). Results. PAT volume 3.2 cm3 and PVAT volume 0.4 cm3 were criteria for high pericardial and high perivascular fat; 81 (25.2%) patients had ectopic obesity, 85 (26.5%) patients abdominal obesity; 146 (42.9%) people had high pericardial fat, 134 (39.4%) high perivascular fat. The frequency of ectopic obesity in patients with arterial hypertension (AH) was statistically significantly higher compared to persons without AH. Significantly more often ectopic forms of obesity were detected in patients with overweight and obesity. The high pericardial fat and high perivascular fat were found in patients with overweight and normal body weight. When comparing the clinical characteristics of patients with abdominal and ectopic obesity, metabolic parameters, as well as the incidence of hypertension and dyslipidemia, did not differ significantly. Conclusion. Ectopic obesity can develop outside of global obesity. In addition, this type of obesity is accompanied by metabolic disorders and AH, regardless of the abdominal distribution of adipose tissue.
- 24 October 2022
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 94 (9) , 1072-1077
Open AccessEctopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics
Aim. To determine the frequency, distribution and characteristics of ectopic obesity in patients without manifested cardiovascular disease. Materials and methods. We examined 320 patients without manifested cardiovascular disease (average age 63.813.9 years), 38 of them without cardiovascular risk factors (healthy referent group). Anthropometric indicators were measured, body mass index (BMI) was calculated. Degree, type of obesity, lipid profile were evaluated. All patients underwent multi-detector chest computed tomography in spiral mode on Toshiba Aquilion Prime scanner using standardized protocol. Perivascular adipose tissue (PVAT) and pericardial adipose tissue (PAT) were detected using specialized semi-automatic software Tissue Composition Module QCTPro (Mindways Software, Inc., USA) after scanner calibration with special phantom. PAT and PVAT exceeding the 90th percentile in the healthy referent group were considered as ectopic obesity. Statistical analysis was performed using Statistica 10.0 software (StatSoft Inc., USA). Results. PAT volume 3.2 cm3 and PVAT volume 0.4 cm3 were criteria for high pericardial and high perivascular fat; 81 (25.2%) patients had ectopic obesity, 85 (26.5%) patients abdominal obesity; 146 (42.9%) people had high pericardial fat, 134 (39.4%) high perivascular fat. The frequency of ectopic obesity in patients with arterial hypertension (AH) was statistically significantly higher compared to persons without AH. Significantly more often ectopic forms of obesity were detected in patients with overweight and obesity. The high pericardial fat and high perivascular fat were found in patients with overweight and normal body weight. When comparing the clinical characteristics of patients with abdominal and ectopic obesity, metabolic parameters, as well as the incidence of hypertension and dyslipidemia, did not differ significantly. Conclusion. Ectopic obesity can develop outside of global obesity. In addition, this type of obesity is accompanied by metabolic disorders and AH, regardless of the abdominal distribution of adipose tissue.
- Open Access
- 20 March 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (1)
Ectopic Fat Depots: Physiological Role And Impact On Cardiovascular Disease Continuum
Obesity is a non-infectious pandemic. The visceral distribution of adipose tissue is a significant factor in the development of cardiovascular diseases and their complications. Along with the visceral abdominal depot in omentum and subcutaneous tissue, there are other ectopic adipose tissue depots: epicardial adipose tissue (EAT), perivascular adipose tissue (PVAT) and perirenal adipose tissue. This article presents a review of the physiological role and molecular basis of the PVAT and EAT function in healthy, as well as in pathological, conditions; the interaction of adipokines and cytokines, their contribution to the development and progression of cardiovascular diseases. The review discusses well-known facts and controversial issues in this field. Comprehensive investigation of the mechanisms of vascular and myocardial pathology in obese people, along with identification of biomarkers for early prediction of cardiovascular complications, would contribute to the development of targeted preventive measures and choice of therapeutic strategies, which is consistent with the contemporary concept of personalized medicine. We have analyzed domestic and foreign literature sources in eLIBRARY and PubMed scientific libraries for the period of 2001-2020.
- 20 March 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (1)
Open AccessEctopic Fat Depots: Physiological Role And Impact On Cardiovascular Disease Continuum
Obesity is a non-infectious pandemic. The visceral distribution of adipose tissue is a significant factor in the development of cardiovascular diseases and their complications. Along with the visceral abdominal depot in omentum and subcutaneous tissue, there are other ectopic adipose tissue depots: epicardial adipose tissue (EAT), perivascular adipose tissue (PVAT) and perirenal adipose tissue. This article presents a review of the physiological role and molecular basis of the PVAT and EAT function in healthy, as well as in pathological, conditions; the interaction of adipokines and cytokines, their contribution to the development and progression of cardiovascular diseases. The review discusses well-known facts and controversial issues in this field. Comprehensive investigation of the mechanisms of vascular and myocardial pathology in obese people, along with identification of biomarkers for early prediction of cardiovascular complications, would contribute to the development of targeted preventive measures and choice of therapeutic strategies, which is consistent with the contemporary concept of personalized medicine. We have analyzed domestic and foreign literature sources in eLIBRARY and PubMed scientific libraries for the period of 2001-2020.
- Open Access
- 15 December 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (12) , 1451-1456
The importance of matrix metalloproteinases in the development of atrial fibrillation in obesity
Background. One of the trends in modern cardiology is the study of the matrix metalloproteinase (MMP) system. Currently, an increase in plasma concentrations of some MMPs and their tissue inhibitors is considered as one of the earliest biochemical markers of myocardial fibrosis in various diseases of the cardiovascular system. Discusses the importance of MMP in the development of atrial fibrillation (AF). Aim. To study the effect of the MMP system on the development of AF in obese patients. Materials and methods. The study included 105 patients with a body mass index of more than 30 kg/m2. Depending on the presence of AF, the patients were divided into 2 groups. The criterion for inclusion of patients in group 1 was the presence of documented AF paroxysm in 55 obese patients. The comparison group (group 2) consisted of 50 obese patients without heart rhythm disorders. When patients were included in the study, in order to assess the severity of visceral obesity, all patients underwent a general clinical examination, echocardiography. To determine the activity of the MMP system, venous blood was taken from patients. Results. Significantly higher values of MMP-9 were detected in patients with obesity and paroxysmal AF 315.753.4 ng/ml than in patients with obesity without heart rhythm disorders 220.954.7 ng/ml (p=0.002); the values of tissue inhibitor of metalloproteinase 1 were 185.342.2 and 119.242.6 ng/ml, respectively (p=0.007). In patients with obesity and paroxysmal AF, a correlation of moderate strength between the level of MMP-9 and the volume of left atrium and a direct dependence of moderate strength between the ratio of waist volume to height and the plasma values of MMP-9 was revealed. The MMP-9 index (AUC 0.92) had a high diagnostic value for determining the probability of having a paroxysmal form of AF in obese patients. With an increase in the level of MMP-9 more than 295 ng/ml, it is possible to predict the presence of paroxysmal AF in obese patients with a sensitivity of 74.5% and a specificity of 94%. Conclusion. In patients with obesity and paroxysmal AF, a significant increase in the parameters of the MMP system (MMP-9 and tissue inhibitor of metalloproteinase 1) was revealed when compared with obese patients without heart rhythm disorders (p0.05). With an increase in MMP-9 of more than 285 ng/ml in obese patients, the appearance of AF with a sensitivity of 74.5% and a specificity of 94% can be predicted.
- 15 December 2021
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 93 (12) , 1451-1456
Open AccessThe importance of matrix metalloproteinases in the development of atrial fibrillation in obesity
Background. One of the trends in modern cardiology is the study of the matrix metalloproteinase (MMP) system. Currently, an increase in plasma concentrations of some MMPs and their tissue inhibitors is considered as one of the earliest biochemical markers of myocardial fibrosis in various diseases of the cardiovascular system. Discusses the importance of MMP in the development of atrial fibrillation (AF). Aim. To study the effect of the MMP system on the development of AF in obese patients. Materials and methods. The study included 105 patients with a body mass index of more than 30 kg/m2. Depending on the presence of AF, the patients were divided into 2 groups. The criterion for inclusion of patients in group 1 was the presence of documented AF paroxysm in 55 obese patients. The comparison group (group 2) consisted of 50 obese patients without heart rhythm disorders. When patients were included in the study, in order to assess the severity of visceral obesity, all patients underwent a general clinical examination, echocardiography. To determine the activity of the MMP system, venous blood was taken from patients. Results. Significantly higher values of MMP-9 were detected in patients with obesity and paroxysmal AF 315.753.4 ng/ml than in patients with obesity without heart rhythm disorders 220.954.7 ng/ml (p=0.002); the values of tissue inhibitor of metalloproteinase 1 were 185.342.2 and 119.242.6 ng/ml, respectively (p=0.007). In patients with obesity and paroxysmal AF, a correlation of moderate strength between the level of MMP-9 and the volume of left atrium and a direct dependence of moderate strength between the ratio of waist volume to height and the plasma values of MMP-9 was revealed. The MMP-9 index (AUC 0.92) had a high diagnostic value for determining the probability of having a paroxysmal form of AF in obese patients. With an increase in the level of MMP-9 more than 295 ng/ml, it is possible to predict the presence of paroxysmal AF in obese patients with a sensitivity of 74.5% and a specificity of 94%. Conclusion. In patients with obesity and paroxysmal AF, a significant increase in the parameters of the MMP system (MMP-9 and tissue inhibitor of metalloproteinase 1) was revealed when compared with obese patients without heart rhythm disorders (p0.05). With an increase in MMP-9 of more than 285 ng/ml in obese patients, the appearance of AF with a sensitivity of 74.5% and a specificity of 94% can be predicted.
- Open Access
- 28 November 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (7) , 2993
Relationship between the volume of perivascular adipose tissue and the vascular wall lesion
Aim. To study the relationship between the volume of perivascular adipose tissue (PVAT) and the vascular wall lesion.Material and methods. The study included 318 patients without cardiovascular disease (mean age, 63,5±13,7 years). Hypertension was detected in 268 (84,3%) patients. All patients underwent assessment of anthropometric characteristics, lipid profile, arterial wall stiffness with the estimation of cardio-ankle vascular index, intima-media thickness, brachial artery endothelial vasomotor function. Chest computed tomography was performed with the estimation of the volumes of PVAT and pericardial adipose tissue (PAT).Results. The volume of PVAT, on average, was 0,3 [0,2; 0,4] cm3 . The VAT volume was significantly higher in obese individuals when compared with patients with normal body weight: 0,4 [0,3; 0,5] vs 0,25 [0,2; 0,4] cm3 (p=0,0007). The VAT volume was higher in individuals with an increased CAVI level when compared with patients with normal CAVI values: 0,4 [0,3; 0,5] vs 0,3 [0,25; 0,3] (p=0,02). A significant correlation was found between the VAT volume and body mass index (r=0,27, pConclusion. The results indicate the relationship of PVAT with visceral obesity and vascular wall stiffness parameters.
- 28 November 2021
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (7) , 2993
Open AccessRelationship between the volume of perivascular adipose tissue and the vascular wall lesion
Aim. To study the relationship between the volume of perivascular adipose tissue (PVAT) and the vascular wall lesion.Material and methods. The study included 318 patients without cardiovascular disease (mean age, 63,5±13,7 years). Hypertension was detected in 268 (84,3%) patients. All patients underwent assessment of anthropometric characteristics, lipid profile, arterial wall stiffness with the estimation of cardio-ankle vascular index, intima-media thickness, brachial artery endothelial vasomotor function. Chest computed tomography was performed with the estimation of the volumes of PVAT and pericardial adipose tissue (PAT).Results. The volume of PVAT, on average, was 0,3 [0,2; 0,4] cm3 . The VAT volume was significantly higher in obese individuals when compared with patients with normal body weight: 0,4 [0,3; 0,5] vs 0,25 [0,2; 0,4] cm3 (p=0,0007). The VAT volume was higher in individuals with an increased CAVI level when compared with patients with normal CAVI values: 0,4 [0,3; 0,5] vs 0,3 [0,25; 0,3] (p=0,02). A significant correlation was found between the VAT volume and body mass index (r=0,27, pConclusion. The results indicate the relationship of PVAT with visceral obesity and vascular wall stiffness parameters.